Rebecca Taub, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 42,555 shares at $551.85 ($20.5M) on 2025-12-10, disclosed to the SEC on 2025-12-12.
Scheduled sale ($20.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,455 | $0 | 0.0% |
| 2 | $547.76 | 491 | $269K | 1.3% |
| 3 | $547.76 | 491 | $269K | 1.3% |
| 4 | $548.56 | 369 | $202K | 1.0% |
| 5 | $548.56 | 369 | $202K | 1.0% |
| 6 | $550.07 | 486 |
| $267K |
| 1.3% |
| 7 | $550.07 | 486 | $267K | 1.3% |
| 8 | $550.99 | 4,723 | $2.6M | 12.7% |
| 9 | $550.99 | 4,723 | $2.6M | 12.7% |
| 10 | $551.85 | 4,410 | $2.4M | 11.9% |
| 11 | $551.85 | 4,410 | $2.4M | 11.9% |
| 12 | $552.81 | 3,857 | $2.1M | 10.4% |
| 13 | $552.81 | 3,857 | $2.1M | 10.4% |
| 14 | $553.88 | 3,087 | $1.7M | 8.3% |
| 15 | $553.88 | 3,087 | $1.7M | 8.3% |
| 16 | $554.84 | 1,027 | $570K | 2.8% |
| 17 | $554.84 | 1,027 | $570K | 2.8% |
| 18 | $555.39 | 200 | $111K | 0.5% |
| Total | $481.36 avg | 42,555 | $20.5M | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |